Cost-effectiveness analysis of simeprevir with daclatasvir for non-cirrhotic genotype-1b-naïve patients plus chronic hepatitis C

  1. Gimeno-Ballester, V.
  2. Mar, J.
  3. San Miguel, R.
Revue:
Expert Review of Pharmacoeconomics and Outcomes Research

ISSN: 1744-8379,  1473-7167

Année de publication: 2016

Volumen: 16

Número: 2

Pages: 285-294

Type: Article

DOI: 10.1586/14737167.2015.1081061 GOOGLE SCHOLAR
La source de données: Scopus